Biomedical Engineering Reference
In-Depth Information
153. Shapiro
AB,
Ling
V.
1997.
Positively
cooperative
sites
for
drug
transport
by
P-glycoprotein with distinct drug specificities. Eur J Biochem 250(1):130-137.
154. Di Pietro A, Conseil G, Perez-Victoria JM, Dayan G, Baubichon-Cortay H, Trompier D,
Steinfels E, Jault JM, de Wet H, Maitrejean M, et al. 2002. Modulation by flavonoids of
cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell
Mol Life Sci 59(2):307-322.
155. Boumendjel A, Di Pietro A, Dumontet C, Barron D. 2002. Recent advances in the dis-
covery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible
for cancer cell multidrug resistance. Med Res Rev 22(5):512-529.
156. Kitagawa S. 2006. Inhibitory effects of polyphenols on P-glycoprotein-mediated trans-
port. Biol Pharm Bull 29(1):1-6.
157. Choi JS, Jo BW, Kim YC. 2004. Enhanced paclitaxel bioavailability after oral adminis-
tration of paclitaxel or prodrug to rats pretreated with quercetin. Eur J Pharm Biopharm
57(2):313-318.
158. Dupuy J, Larrieu G, Sutra JF, Lespine A, Alvinerie M. 2003. Enhancement of moxidectin
bioavailability in lamb by a natural flavonoid: quercetin. Vet Parasitol 112(4):337-347.
159. Hsiu SL, Hou YC, Wang YH, Tsao CW, Su SF, Chao PD. 2002. Quercetin significantly
decreased cyclosporin oral bioavailability in pigs and rats. Life Sci 72(3):227-235.
160. Trompier D, Baubichon-Cortay H, Chang XB, Maitrejean M, Barron D, Riordon JR,
Di Pietro A. 2003. Multiple flavonoid-binding sites within multidrug resistance protein
MRP1. Cell Mol Life Sci 60(10):2164-2177.
161. van Zanden JJ, Geraets L, Wortelboer HM, van Bladeren PJ, Rietjens IM, Cnubben
NH. 2004. Structural requirements for the flavonoid-mediated modulation of glutathione
S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Phar-
macol 67(8):1607-1617.
162. van Zanden JJ, Wortelboer HM, Bijlsma S, Punt A, Usta M, Bladeren PJ, Rietjens IM,
Cnubben NH. 2005. Quantitative structure activity relationship studies on the flavonoid
mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol
69(4):699-708.
163. Lania-Pietrzak B, Michalak K, Hendrich AB, Mosiadz D, Grynkiewicz G, Motohashi
N, Shirataki Y. 2005. Modulation of MRP1 protein transport by plant, and synthetically
modified flavonoids. Life Sci 77(15):1879-1891.
164. Imai Y, Tsukahara S, Asada S, Sugimoto Y. 2004. Phytoestrogens/flavonoids reverse
breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res
64(12):4346-4352.
165. Zhang S, Yang X, Coburn RA, Morris ME. 2005. Structure activity relationships and
quantitative structure activity relationships for the flavonoid-mediated inhibition of breast
cancer resistance protein. Biochem Pharmacol 70(4):627-639.
166. Ahmed-Belkacem A, Pozza A, Munoz-Martinez F, Bates SE, Castanys S, Gamarro
F, Di Pietro A, Perez-Victoria JM. 2005. Flavonoid structure-activity studies identify
6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resis-
tance protein ABCG2. Cancer Res 65(11):4852-4860.
167. Hecht SS. 1995. Chemoprevention by isothiocyanates. J Cell Biochem Suppl 22:195-209.
168. Talalay P, Fahey JW. 2001. Phytochemicals from cruciferous plants protect against cancer
by modulating carcinogen metabolism. J Nutr 131(11 Suppl):3027S-3033S.
Search WWH ::
Custom Search